MARCH 2020CIOAPPLICATIONS.COM6Copyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.March - 23, 2020, Volume 06 - Issue 06 (ISSN 2644-240X) Published by ValleyMedia, Inc. To subscribe to CIO ApplicationsVisit www.cioapplications.com Managing EditorJoe Phillip*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffSalesSebastian Jacobsebastian@cioapplications.comEmailsales@cioapplications.comeditor@cioapplications.commarketing@cioapplications.comContact UsPhone: 510.330.5174Fax: 510.894.8405EditorialBiotech beyond Medicinal BoundariesThe biotech sector has been hit by the wave of digitalization and has undergone some rapid transformation in the last few years. Pharmaceutical companies have stepped up their game and are manufacturing drugs to cure diseases that were though incurable in the past. Gene editing in humans has reached new levels and is pending approval from authorities. Apart from the medicinal discoveries, biotech is also leading the way in areas such as chemical manufacturing, laundry services, petrochemicals, and many more. Along with the advancements fueled by biotech, there is also the impact it has had on social responsibility. Biotech developments have helped curb down greenhouse gas emissions and also tackle the problem of water shortage, to a large extentLarge molecule therapies produced from living cells were once considered the pinnacle of biotech. Decades later, thanks to cutting edge biotech, medical professionals have at their disposal a range of sophisticated drug platforms, from new twists on monoclonal antibodies to nucleic acid therapies and gene-based medicines. The interest in these new services has been immense as more and more organizations look to invest in the research and development of these drugs. Gene-based therapy has caught the attention of quite a few pharmaceuticals, suggesting that these expensive therapies could actually have a viable future.Regardless of how much aversion the idea of human-animal chimeras creates, the notion has gained significant traction over the years and has seen a few breakthroughs throughout 2019. Xenotransplants have come a long way in the last few years, overcoming some of the most significant challenges posed. Pigs that are treated and genetically modified at a young age can be used for organ replacement in humans once they come of the right age. This has been made possible after rigorous work in the xenotransplant sector, and the first pig to human transplant could happen within the coming two years.The field of biotech is undergoing rapid changes and transforming the way we look at medicine. To help our readers find the most suitable company for their needs, we have compiled a list of the most holistic solution providers in the industry.Do let us know your thoughts!Joe PhillipManaging Editoreditor@cioapplications.comJoe PhillipGraphics & ArtIssac GeorgeEditorial StaffBen JacksonDaniel HolmesEzra BenjaminJune MichaelRose DcruzSenior WritersClara MathewLeah JaneRoyce D'Souza
< Page 5 | Page 7 >